Literature DB >> 3902988

A specific inhibitor of keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. albicans.

R Tsuobi, Y Kurita, M Negi, H Ogawa.   

Abstract

The authors investigated the influence of culture medium pH and various kinds of protease inhibitors on the growth of Candida albicans when cultivated in liquid medium containing human stratum corneum (HSC) as the nitrogen source. Rapid growth of C. albicans was observed with weakly acidic media, particularly at pH 4.0. From among the various kinds of protease inhibitors added to the media at pH 4.0, pepstatin, a carboxyl protease inhibitor, most strongly inhibited the growth of C. albicans dependent upon its concentration. The antifungal effect of pepstatin was not fungicidal, but was nevertheless effective even at a very low concentration of 0.01 microgram/ml. This inhibitory effect of pepstatin was considerably stronger than that of the well-known antifungal agent, clotrimazole. Pepstatin is a specific inhibitor of keratinolytic proteinase (KPase) from C. albicans; it belongs to the carboxyl proteinases group and has an optimum pH at 4.0. Pepstatin showed a strong antifungal effect, possibly through KPase inhibition, in biologic (HSC) medium that was similar to that encountered in vivo. Our results suggest that KPase may play an important role in the growth of C. albicans and that pepstatin has the possibility of being used as a new type of antifungal agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902988     DOI: 10.1111/1523-1747.ep12277147

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Extracellular proteinase production and the pathogenicity of Nocardiae.

Authors:  R Tsuboi; T Yamaguchi; K Matsuda; H Ogawa
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

3.  Isolation and properties of extracellular proteinases from Sporothrix schenckii.

Authors:  R Tsuboi; T Sanada; K Takamori; H Ogawa
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

4.  Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent.

Authors:  A M Edison; M Manning-Zweerink
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Correlation between culture medium pH, extracellular proteinase activity, and cell growth of Candida albicans in insoluble stratum corneum-supplemented media.

Authors:  R Tsuboi; K Matsuda; I J Ko; H Ogawa
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

6.  Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii.

Authors:  R Tsuboi; T Sanada; H Ogawa
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

7.  Anti-Candida and mode of action of two newly synthesized polymers: a modified poly (methylmethacrylate-co-vinylbenzoylchloride) and a modified linear poly (chloroethylvinylether-co-vinylbenzoylchloride) with special reference to Candida albicans and Candida tropicalis.

Authors:  Yehia A G Mahmoud; Magda M Aly
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

8.  Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa.

Authors:  M Borg; R Rüchel
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

9.  Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase.

Authors:  T L Ray; C D Payne
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Antibody raised against extracellular proteinases of Sporothrix schenckii in S. schenckii inoculated hairless mice.

Authors:  T Yoshiike; P C Lei; H Komatsuzaki; H Ogawa
Journal:  Mycopathologia       Date:  1993-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.